Table 1 Maternal cytokine values before and after supplementation
From: Effect of prenatal EPA and DHA on maternal and umbilical cord blood cytokines
| LLD | Enrollment 1 N = 126 | Post-supplementation N = 113 | ||||
|---|---|---|---|---|---|---|
| median | IQR | median | IQR | |||
| IL1α | 6.664 | EPA | 6.66 | (6.66,11.3) | 6.66 | (6.66,6.66) |
| DHA | 6.66 | (6.66,15.4) | 6.66 | (6.66,6.66) | ||
| Placebo | 6.66 | (6.66,6.66) | 6.66 | (6.66,10.6) | ||
| IL1β | 7.806 | EPA | 13.2 | (7.81,48.5) | 15.7 | (7.81,68.7) |
| DHA | 7.81 | (7.81,48) | 16.3 | (7.81,63.6) | ||
| Placebo | 9.65 | (7.81,46.7) | 23 | (7.81,74.2) | ||
| IL2 | 2.584 | EPA | 26.7 | (2.58,64.1) | 23.1 | (6.4,57.9) |
| DHA | 27.9 | (6.1,71.4) | 15.5 | (2.58,48.1) | ||
| Placebo | 30.5 | (2.58,61.8) | 28.2 | (2.58,61.7) | ||
| IL4 | 0.776 | EPA | 0.776 | (0.78,4.7) | 0.776 | (0.776,2.5) |
| DHA | 0.776 | (0.78,3.8) | 0.776 | (0.776,6.2) | ||
| Placebo | 0.776 | (0.78,3.7) | 0.776 | (0.776,2.15) | ||
| IL5 | 35.05 | EPA | 35.1 | (35.1106) | 35.1 | (35.1107) |
| DHA | 35.1 | (35.1,48.4) | 35.1 | (35.1128) | ||
| Placebo | 35.1 | (35.1,67.9) | 35.1 | (35.1,95.2) | ||
| IL6 | 18.466 | EPA | 18.5 | (18.5,41.8) | 18.5 | (18.5,23.6) |
| DHA | 18.5 | (18.5,18.5) | 18.5 | (18.5,50.2) | ||
| Placebo | 18.5 | (18.5,18.5) | 18.5 | (18.5,36.8) | ||
| IL8 | 9.894 | EPA | 9.89 | (9.89,18.7) | 9.89 | (9.89,38.4) |
| DHA | 9.89 | (9.89,12) | 9.89 | (9.89,24.3) | ||
| Placebo | 9.89 | (9.89,9.89) | 9.89 | (9.89,26.9) | ||
| IL10 | 2.94 | EPA | 2.94 | (2.94,48.3) | 2.94 | (2.94,32.5) |
| DHA | 2.94 | (2.94,37.3) | 2.94 | (2.94,57.4) | ||
| Placebo | 2.94 | (2.94,43.3) | 2.94 | (2.94,36.0) | ||
| IL12p70 | 45.458 | EPA | 45.5 | (45.5,99.3) | 45.5 | (45.5108) |
| DHA | 45.5 | (45.5,71.7) | 45.5 | (45.5,76) | ||
| Placebo | 45.5 | (45.5154) | 45.5 | (45.5,94.1) | ||
| IL13 | 12.608 | EPA | 12.6 | (12.6,55.3) | 12.6 | (12.6,29.2) |
| DHA | 12.6 | (12.6,58.6) | 12.6 | (12.6,42.8) | ||
| Placebo | 12.6 | (12.6,33.1) | 12.6 | (12.6,44) | ||
| IL15 | 7.734 | EPA | 7.73 | (7.73,29.2) | 7.73 | (7.73,7.73) |
| DHA | 7.73 | (7.73,7.73) | 7.73 | (7.73,13.2) | ||
| Placebo | 7.73 | (7.73,7.73) | 7.73 | (7.73,25) | ||
| IL17 | 45.586 | EPA | 45.6 | (45.6,49.7) | 45.6 | (45.6,45.6) |
| DHA | 45.6 | (45.6,45.6) | 45.6 | (45.6,45.6) | ||
| Placebo | 45.6 | (45.6,86.9) | 45.6 | (45.6,59.8) | ||
| IFNγ | 58.506 | EPA | 58.5 | (58.5104) | 58.5 | (58.5294) |
| DHA | 58.5 | (58.5156) | 58.5 | (58.5206) | ||
| Placebo | 58.5 | (58.5142) | 58.5 | (58.5159) | ||
| MPC1 | 5.686 | EPA | 125 | (83.6224) | 139 | (82.6212) |
| DHA | 118 | (75.9228) | 107 | (60.2183) | ||
| Placebo | 138 | (88,183) | 129 | (75.1171) | ||
| TNFα | 15.146 | EPA | 15.1 | (15.1114) | 15.1 | (15.1,46.9) |
| DHA | 15.1 | (15.1,15.1) | 15.1 | (15.1,41.5) | ||
| Placebo | 15.1 | (15.1,48.2) | 15.1 | (15.1,58.1) | ||
| TNFβ | 4.956 | EPA | 4.96 | (4.96,10.9) | 4.96 | (4.96,4.96) |
| DHA | 4.96 | (4.96,10.5) | 4.96 | (4.96,15.8) | ||
| Placebo | 4.96 | (4.96,16.5) | 4.96 | (4.96,4.96) | ||
